{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:19Z","timestamp":1740134899303,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,23]]},"DOI":"10.1182\/blood.2022018509","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T16:37:03Z","timestamp":1677170223000},"page":"816-818","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Meet the Burkitts: a dark zone family"],"prefix":"10.1182","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-6658","authenticated-orcid":false,"given":"Adam J.","family":"Olszewski","sequence":"first","affiliation":[{"name":"1Alpert Medical School of Brown University"},{"name":"2Rhode Island Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"8","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"12","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt\u2019s lymphoma","volume":"387","author":"Roschewski","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.20.03288","article-title":"Burkitt lymphoma international prognostic index","volume":"39","author":"Olszewski","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjh.17874","article-title":"Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features","volume":"196","author":"Richter","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"Lopez","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1541-7786.MCR-20-0466","article-title":"Aggressive B-cell lymphoma with MYC\/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents","volume":"19","author":"Deng","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"10036","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0140-6736(15)01317-3","article-title":"Rituximab and dose-dense chemotherapy for adults with Burkitt\u2019s lymphoma: a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Ribrag","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"2023022316365730200_","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.20.00303","article-title":"Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma","volume":"38","author":"Roschewski","year":"2020","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/8\/816\/2035086\/blood_bld-2022-018509-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/8\/816\/2035086\/blood_bld-2022-018509-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T09:47:22Z","timestamp":1679824042000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/8\/816\/494513\/Meet-the-Burkitts-a-dark-zone-family"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,2,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022018509","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}